Picture of Sangui Biotech International logo

SGBI — Sangui Biotech International News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Sangui Biotech 9M Revenues From Royalty Income At USD 51,754

May 10 (Reuters) - SANGUI BIOTECH INTERNATIONAL INC
 SGBI.BE :
    * 9M OPERATING LOSS -111,000 USD
    * NINE MONTH OPERATING LOSS DECREASED USD 18,847 TO USD
111,039
    * LOSS OF NINE MONTH PERIOD INCREASED BY USD 24,513 TO USD
151,923.
    * 9M REVENUES FROM ROYALTY INCOME OF USD 51,754

Source text for Eikon:  ID:nEQ26Lwn8a 
Further company coverage:  SGBI.BE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))

Recent news on Sangui Biotech International

See all news